This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2005 Sep;85(3):222-9.

doi: 10.1590/s0066-782x2005001600016. Epub 2005 Sep 29.

[Cardiovascular events: a class effect by COX-2 inhibitors]

[Article in Portuguese]

Leila Fernandes Araujo¹, Alexandre de Matos Soeiro, Juliano de Lara Fernandes, Carlos Vicente Serrano Júnior

Affiliations

PMID: 16200274
DOI: 10.1590/s0066-782x2005001600016

Free article

Review

[Cardiovascular events: a class effect by COX-2 inhibitors]

[Article in Portuguese]

Leila Fernandes Araujo et al. Arq Bras Cardiol. 2005 Sep.

Free article

. 2005 Sep;85(3):222-9.

doi: 10.1590/s0066-782x2005001600016. Epub 2005 Sep 29.

Authors

Leila Fernandes Araujo¹, Alexandre de Matos Soeiro, Juliano de Lara Fernandes, Carlos Vicente Serrano Júnior

Affiliation

¹ Instituto do Coração, Hospital das Clínicas, FMUSP, São Paulo, SP.

PMID: 16200274
DOI: 10.1590/s0066-782x2005001600016

No abstract available

PubMed Disclaimer

Similar articles

Lessons to learn from the COX-2 saga. Yes, FDA reforms are needed. And marketing distorts how medications are used. But one moral to the story is that all drugs have risks.
[No authors listed] [No authors listed] Harv Health Lett. 2005 Mar;30(5):1-3. Harv Health Lett. 2005. PMID: 16526110 No abstract available.
COX-2 inhibitors and the heart: putting risk in perspective.
Bobadilla RV, Barnett EM, Randels CL. Bobadilla RV, et al. Adv Nurse Pract. 2005 Nov;13(11):48-50. Adv Nurse Pract. 2005. PMID: 16295003 Review. No abstract available.
Cyclooxygenase-2 inhibitors and cardiovascular risk.
Smith ER. Smith ER. Can J Cardiol. 2005 Mar;21(3):307-8. Can J Cardiol. 2005. PMID: 15776124 English, French. No abstract available.
[Innovation of anti-inflammatory drugs--inhibition of cyclooxygenases].
Guo ZR. Guo ZR. Yao Xue Xue Bao. 2005 Nov;40(11):967-9. Yao Xue Xue Bao. 2005. PMID: 16499077 Review. Chinese. No abstract available.
Temporal relationship between use of NSAIDs, including selective COX-2 inhibitors, and cardiovascular risk.
Motsko SP, Rascati KL, Busti AJ, Wilson JP, Barner JC, Lawson KA, Worchel J. Motsko SP, et al. Drug Saf. 2006;29(7):621-32. doi: 10.2165/00002018-200629070-00007. Drug Saf. 2006. PMID: 16808554

See all similar articles

Cited by

Anticancer and anti-inflammatory properties of chitin and chitosan oligosaccharides.
Azuma K, Osaki T, Minami S, Okamoto Y. Azuma K, et al. J Funct Biomater. 2015 Jan 14;6(1):33-49. doi: 10.3390/jfb6010033. J Funct Biomater. 2015. PMID: 25594943 Free PMC article. Review.
Safety Assessment of an Oral Therapeutic Dose of Firocoxib on Healthy Horses.
Araújo RA, Sales NAA, Basile RC, Feringer-Junior WH, Apparício M, Ferraz GC, Queiroz-Neto A. Araújo RA, et al. Vet Sci. 2023 Aug 22;10(9):531. doi: 10.3390/vetsci10090531. Vet Sci. 2023. PMID: 37756053 Free PMC article.
Clinical use and pharmacological properties of selective COX-2 inhibitors.
Shi S, Klotz U. Shi S, et al. Eur J Clin Pharmacol. 2008 Mar;64(3):233-52. doi: 10.1007/s00228-007-0400-7. Epub 2007 Nov 13. Eur J Clin Pharmacol. 2008. PMID: 17999057 Review.
Identification of Potential COX-2 Inhibitors for the Treatment of Inflammatory Diseases Using Molecular Modeling Approaches.
Araújo PHF, Ramos RS, da Cruz JN, Silva SG, Ferreira EFB, de Lima LR, Macêdo WJC, Espejo-Román JM, Campos JM, Santos CBR. Araújo PHF, et al. Molecules. 2020 Sep 12;25(18):4183. doi: 10.3390/molecules25184183. Molecules. 2020. PMID: 32932669 Free PMC article.
Low-level laser irradiation, cyclooxygenase-2 (COX-2) expression and necrosis of random skin flaps in rats.
Esteves Junior I, Masson IB, Oshima CT, Paiotti AP, Liebano RE, Plapler H. Esteves Junior I, et al. Lasers Med Sci. 2012 May;27(3):655-60. doi: 10.1007/s10103-011-1011-1. Epub 2011 Oct 21. Lasers Med Sci. 2012. PMID: 22016040

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Scientific Electronic Library Online
Other Literature Sources
- The Lens - Patent Citations Database
Research Materials
- NCI CPTC Antibody Characterization Program